Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.39 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | SLC1A5 | Q15758 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3075848 | 0.86 | PTGS1 (0.43) | PTGS1SLC7A11NOS3NOS1NOS2 | |
| Serine SCHEMBL4887746 | 0.83 | PTGS1 (0.43) | PTGS1SLC7A11NOS3NOS1NOS2 | |
| Cysteine SCHEMBL2597897 | 0.81 | PTGS1 (0.59) | PTGS1SLC7A11NOS3NOS1NOS2 | |
| SCHEMBL1514151 | 0.80 | NOS3 (0.41) | PTGS1SLC7A11NOS3NOS1NOS2 | |
| Cysteine SCHEMBL15417922 | 0.79 | PTGS1 (0.42) | PTGS1SLC7A11NOS3NOS1NOS2 | |
| Glycine SCHEMBL12500492 | 0.78 | SLC1A5 (0.36) | PTGS1SLC7A11NOS3NOS1NOS2 | |
| SCHEMBL16058499 | 0.77 | PTGS1 (0.48) | PTGS1SLC7A11NOS3NOS1NOS2 | |
| SCHEMBL352049 | 0.76 | SLC1A5 (0.43) | PTGS1SLC7A11NOS3NOS1NOS2 | |
| SCHEMBL3502798 | 0.76 | SLC1A5 (0.43) | PTGS1SLC7A11NOS3NOS1NOS2 | |
| SCHEMBL4752999 | 0.75 | SLC1A5 (0.40) | PTGS1SLC7A11NOS3NOS1NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7320784-B1 | Immobilized labeling compounds and methods | BRACCO IMAGING S.P.A. (IT) | 2008-01-22 | — | — | US | disclosed |
| EP-1047708-B1 | PEPTIDE CHELATORS THAT PREDOMINATELY FORM A SINGLE STEREOISOMERIC SPECIES UPON COORDINATION TO A METAL CENTER | BRACCO INT BV (NL) | 2007-09-26 | — | — | EP | disclosed |
| EP-1154803-B1 | IMMOBILIZED LABELING COMPOUNDS AND METHODS | BRACCO INT BV (NL) | 2004-11-17 | — | — | EP | disclosed |
| US-6334996-B1 | RADIOLABELS FOR TARGETING SPECIFIC DIAGNOSTIC PHARMACEUTICALS | RESOLUTION PHARMACEUTICALS INC. (CA) | 2002-01-01 | — | — | US | disclosed |
| EP-1154803-A1 | IMMOBILIZED LABELING COMPOUNDS AND METHODS | Bracco International B.V. (NL) | 2001-11-21 | — | — | EP | disclosed |
| EP-1047708-A1 | PEPTIDE CHELATORS THAT PREDOMINATELY FORM A SINGLE STEREOISOMERIC SPECIES UPON COORDINATION TO A METAL CENTER | RESOLUTION PHARMACEUTICALS INC. (CA) | 2000-11-02 | — | — | EP | disclosed |
| WO-2000048639-A1 | IMMOBILIZED LABELING COMPOUNDS AND METHODS | RESOLUTION PHARMACEUTICALS INC. (CA) | 2000-08-24 | — | — | WO | disclosed |
| EP-1007106-A1 | COMBINATORIAL LIBRARY | RESOLUTION PHARMACEUTICALS INC. (CA) | 2000-06-14 | — | — | EP | disclosed |
| US-6017511-A | USING A METAL CHELATOR COUPLED TO A GLYCOPEPTIDE ANTIBIOTIC FOR IMAGING SITES OF INFLAMMATION, PARTICULARLY THOSE CAUSED BY INFECTION, IN HUMANS | RESOLUTION PHARMACEUTICALS INC. (CA) | 2000-01-25 | — | — | US | disclosed |
| WO-1999033863-A1 | PEPTIDE CHELATORS THAT PREDOMINATELY FORM A SINGLE STEREOISOMERIC SPECIES UPON COORDINATION TO A METAL CENTER | RESOLUTION PHARMACEUTICALS INC. (CA) | 1999-07-08 | — | — | WO | disclosed |
| WO-1999010016-A1 | COMBINATORIAL LIBRARY | RESOLUTION PHARMACEUTICALS INC. (CA) | 1999-03-04 | — | — | WO | disclosed |